Toronto – October 07, 2026 -- Vector Science and Therapeutics Corp. (TSXV: PAIN) has made an investment in Scoreboard, Inc., a performance wellness company co-founded by NBA Hall of Famer Gary Payton, through a Simple Agreement for Future Equity.
Vector and Scoreboard will co-develop peptide-based products for athletic performance, recovery and longevity
The two companies plan to jointly develop products using peptides formulated and manufactured by Vector, which tests all materials for purity, potency, endotoxin levels and sterility through validated analytical methods.
Vector holds 15 pending patent applications covering peptide delivery technology
The Company's intellectual property portfolio spans multi-route peptide and biologic delivery, lyophilized peptide formulations with point-of-care reconstitution, and advanced transdermal delivery systems. Vector states this technology allows peptides -- typically unstable once in liquid or gel form -- to retain potency and remain shelf-stable, a capability central to the Scoreboard collaboration.
Gary Payton II of the Golden State Warriors, a Scoreboard co-founder, cited testing standards as the basis for the partnership
"Working with Vector gives Scoreboard a partner that takes testing and standards as seriously as we do,